Methicillin-resistant Staphylococcus aureus is problematic both in hospitals and in the community. Currently, we have limited understanding of mechanisms of innate immune evasion used by S. aureus. To that end, we created an isogenic deletion mutant in strain MW2 (USA400) of the saeR/S 2-component gene regulatory system and studied its role in mouse models of pathogenesis and during human neutrophil interaction. In this study, we demonstrate that saeR/S plays a distinct role in S. aureus pathogenesis and is vital for virulence of MW2 in a mouse model of sepsis. Moreover, deletion of saeR/S significantly impaired survival of MW2 in human blood and after neutrophil phagocytosis. Microarray analysis revealed that SaeR/S of MW2 influences expression of a wide variety of genes with diverse biological functions. These data provide new insight into how virulence is regulated in S. aureus and associates a specific staphylococcal gene-regulatory system with invasive staphylococcal disease.
Staphylococcus aureus is a leading cause of human infections worldwide. It is the causative agent of diverse diseases that range in severity from mild to life threatening [1] . Recently, there has been an increase in the incidence of community-associated methicillin-resistant S. aureus (MRSA) infection among otherwise healthy individuals. Community-associated MRSA primarily causes skin and soft-tissue infections, but the most prominent strains, classified as pulsed-field gel electrophoresis types USA300 and USA400, have also been associated with severe syndromes or pathologies, including septicemia, necrotizing pneumonia, and necrotizing fasciitis [2] [3] [4] [5] [6] .
Human polymorphonuclear leukocytes (PMNs or neutrophils) are the first line of defense against bacterial infections. The ability of S. aureus to circumvent destruction by innate immunity includes survival after PMN phagocytosis [7] . The ability of S. aureus to survive after PMN phagocytosis is dependent on the pathogen's ability to moderate the hostile environment of PMN phagosome. However, specific mechanisms used by S. aureus to survive after PMN phagocytosis are incompletely defined.
In previous studies, we used oligonucleotide and complementary DNA (cDNA) microarrays to identify complex transcriptional regulation used by S. aureus and group A Streptococcus to survive after PMN phagocytosis [7, 8] . These studies revealed a role for 2-component gene regulatory systems during host cellpathogen interaction. Several 2-component systems were up-regulated by S. aureus during human PMN phagocytosis, including the saeR/S gene regulatory system [7] . The Sae regulatory system was designated "Sae," which stands for S. aureus exoprotein expression, because of altered exoprotein production in sae mutant strains [9 -11] . Several investigators have demonstrated a role for SaeR/S in the regulation of virulence factors [9, [12] [13] [14] [15] [16] [17] [18] . However, the role of saeR/S in the evasion of innate immunity has not been directly investigated. To that end, we generated an saeR/S isogenic deletion mutant in MW2 (USA400), the prototype community-associated MRSA strain, and investigated the fundamental role of saeR/S during innate immune evasion.
MATERIALS AND METHODS
Bacterial strains and culture. The S. aureus MW2 (USA400) strain was selected on the basis of clinical relevance and available genome sequence information [2, 19 -22] . S. aureus was cultured and harvested as described elsewhere [7, 23] .
Construction of MW2 isogenic saeR/S deletion mutant (⌬saeR/S).
To delete saeR/S in MW2, polymerase chain reaction (PCR)-amplified regions flanking the saeR/S locus were cloned into a spectinomycin cassette containing plasmid pBT2spec with use of a previously published protocol [24] . DNA fragments upstream (PCR fragment 1) of saeR/S (5'-GCAA-CCCATGAGCTCAAACACTTCCTGTTCAC-3' and 5'-CCGC-TAGTTGTCGTTGTTACTTTGGATCCTTCATATTC-3') and downstream (PCR fragment 2: 5'-GCAGTCGACTAGATGA-TGTAGGAACTACGATGACTGTAACATTAC-3' and 5'-CTA-TTTGATAAAACAATACTCAGGTACAAGCTTAATCTTTT-AAATAAAAAGGATG-3') were amplified by PCR (restriction sites are shown in boldface). The PCR product was transformed into TOPO TA PCR 2.1 cloning vector (TOPO; Invitrogen Life Technologies), and the sequence of the purified product was verified by nucleotide sequencing. Left and right fragments were ligated to plasmid pBT2spec [24, 25] . The resulting plasmid, pBT⌬saeR/S, was transformed sequentially into Escherichia coli and S. aureus strains RN4220 and MW2. The MW2 construct was used for allelic replacement, as described elsewhere [24] . Lack of saeR/S transcripts in the saeR/S mutant strain (⌬saeR/S) was verified by TaqMan real-time PCR (ABI 7500 Thermocycler Applied Biosystems) (figure 1A) and by PCR (figure 2). For the saeR/S-complemented strain, saeR/S genes were cloned into TOPO with use of primers 5'-GGTATAAGTGGATC-CTCGCAAATATAGTTGCACATACGAC-3' and 5'-GCC-CTCATTAATGGGAGCAAGCTTTTAGTCTTTGC-3', were cloned into plasmid pRB473 [24] , and were transformed into S. aureus strain ⌬saeR/S. Mouse infection models. All studies conformed to National Institutes of Health guidelines and were approved by the Animal Care and Use Committee at Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, and Montana State University. Female CD1 Swiss and Crl:SKH1-hrBR hairless mice were purchased from Charles River Laboratories. MW2 wild-type and ⌬saeR/S S. aureus strains were cultured to the midexponential phase of growth, were washed twice with sterile Dulbecco's phosphate-buffered saline (DPBS), and were resuspended in DPBS at a concentration of 1 ϫ 10 8 cells per 100 L.
Mice were inoculated with MW2 or ⌬saeR/S, and control animals received DPBS. Fifteen mice were used for each strain and/or control group in each model. For the sepsis model, CD1 Swiss mice were inoculated by tail vein injection with 1 ϫ 10 8 S. aureus in 100 L, as reported elsewhere [7, 23] . Mice were monitored every 2 h for the first 48 h. If animals were unable to eat or drink or if they became immobile, they were euthanized. Survival statistics were performed using a log-rank test (GraphPad Prism, version 4.0 for Windows; GraphPad Software).
For the abscess model, Crl:SKH1-hrBR mice were inoculated by subcutaneous injection in the right flank with 1 ϫ 10 7 S. aureus or DPBS. The abscess size was calculated using the formula for a spherical ellipsoid [26] : Figure 1 . TaqMan real-time reverse transcription polymerase chain reaction (RT-PCR) confirmation of mutant phenotype. A, Restoration of saeR/S expression (comparable to that of wild-type MW2) through complementation of the saeR/S mutant strain. B, Genes (n ϭ 7) identified as differentially transcribed by microarray analysis that were selected from several categories for confirmation by TaqMan real-time RT-PCR. Transcript levels were measured either during the midexponential (ME; optical density at 600 nm, 0.75) or early stationary (ES) phases of growth (optical density at 600 nm, 2.0). Samples were analyzed in triplicate, and results are from 2 biological repetitions. There was a positive correlation between TaqMan and microarray results, consistent with previous comparisons. Comp, complement.
To determine bacterial burden in abscesses, mice were inoculated subcutaneously with S. aureus as described above, and 3 mice per treatment group were euthanized on designated days. Abscesses were excised, homogenized in 2 mL of DPBS, and plated on tryptic soy agar for determination of the number of colony-forming units (cfu).
S. aureus survival in human blood. Heparinized venous blood samples from healthy donors were collected in accordance with a protocol approved by the Institutional Review Board for Human Subjects, National Institute of Allergy and Infectious Diseases, and Montana State University. All donors provided written consent to participate in the study. MW2 and ⌬saeR/S were harvested at the midexponential phase of growth. One milliliter of heparinized human blood was inoculated with ϳ1 ϫ 10 5 cfu of S. aureus and was incubated at 37°C for 1 h and 3 h with shaking (250 rpm). The percentage of S. aureus cfu that survived in blood was determined by comparing the bacterial burden in each sample after 1 h or 3 h with the bacterial burden at the start of the assay (0 h). Statistical analysis was performed using repeated-measures analysis of variance and Tukey's posttest for multiple comparisons (GraphPad Prism, version 4.0 for Windows; GraphPad Software).
Human PMN assays. PMNs were isolated under endotoxinfree conditions (Ͻ25.0 pg/mL), as described elsewhere [7] . Cell viability and purity of preparations were assessed by flow cytometry (FACSCalibur; BD Biosciences). Cell preparations contained ϳ99% PMNs. Phagocytosis of human serum-opsonized MW2 and ⌬saeR/S was synchronized by centrifugation with use of a published method [27] , and the percentage of MW2 and ⌬saeR/S ingested was determined using fluorescence microscopy, as described elsewhere [7] . PMN bactericidal activity was determined using methods described elsewhere [7, 28] . Colonies were enumerated the following day, and the percentage of S. aureus cfu that survived was determined. The assay measures viable ingested and uningested bacteria. PMN lysis after phagocytosis of MW2 was determined using a fluorescence-based assay for release of lactate dehydrogenase according to the manufacturer's instructions (CytoTox-One Homogenous Membrane Integrity Assay; Promega). Statistical analyses were performed using repeated-measures analysis of variance and Tukey's post-test for multiple comparisons (GraphPad Prism, version 4.0).
S. aureus gene expression. To compare transcript levels of MW2 and saeR/S, bacteria were grown to midexponential (optical density at 600 nm, 0.75) and early stationary (optical density at 600 nm, 2.0) phases and were processed for microarray analysis as described elsewhere [7] . S. aureus cDNA was hybridized to custom Affymetrix GeneChips (RMLChip 3) containing 99.3% coverage of genes from MW2 (2613 probe sets of 2632 open reading frames, with the remaining 0.7% represented by identical probe sets from other staphylococci). Samples were scanned in accordance with standard GeneChip protocols [29] . Each experiment was repeated in triplicate. Microarray data were analyzed using GeneChip operating software, verson 1.1 (Affymetrix) , and GeneSpring, version 7.0 (Silicon Genetics). Microarray data are posted on the Gene Expression Omnibus (accession number GSE15067; available at: http://www.ncbi .nlm.nih.gov/geo/). To compare gene expression between MW2 and ⌬saeR/S strains, fold changes for each transcript were determined by comparing RMLChips hybridized with cDNA from MW2 with those with cDNA from ⌬saeR/S (comparisons were matched by growth phase).
TaqMan real-time reverse transcription PCR analysis. RNA preparations for TaqMan analysis were performed with procedures and conditions identical to those used for microarray experiments. Relative quantification of S. aureus genes was determined by the change in expression of target transcripts relative to that of the housekeeping gene gyrB. Fold change was determined by comparing transcript expression in strains MW2 and complement ⌬saeR/S with expression in ⌬saeR/S (according to the Applied Biosystems Relative Quantification Manual [30] ). Primer probe sequences used for confirmation of saeR/S deletion and microarray results were as follows: gyrB forward primer (5'-CAAATGATCA-CAGCATTTGGTACAG-3'), gyrB probe (5'-AATCGGTGGCGA-CTTTGATCTAGCGAAAG-3'), and gyrB reverse primer (5'-C-GGCATCAGTCATAATGACGAT-3'); saeS forward primer (5'-CGTACATTCAGAGTAGAAAACTCTCGTAATAC-3'), saeS probe (5'-AGCCTAATCCAGAACCACCCGTT-3'), and saeS reverse primer (5'-GTTGCGCGAGTTCATTAG CT-ATATAT-3'); saeR forward primer (5'-CTGCCAAAACAC-A A G A A C A T G A T A C -3 ' ) , s a e R p r o b e ( 5 ' -A T T T A -CGCCTTAACTTTAGGTGCAGAT-3'), and saeR reverse primer (5'-CTTGGACTAAATGGTTTTTTGACATAGT-3'); sbi forward primer (5'-ATACATCAAAACATTACGCGAACAC-3'), sbi probe (5'-CAGAACGTGCACAAGAAGTATTCTCTGAA-3'), and sbi reverse primer (5'-CTGGGTTCTTGCTGTCTTTAAGTG-3'); orf4 forward primer (5'-TGGTGCTGTTGCCTCTGTATTAA-3'), orf4 probe(5'-TTTAGGCGCTTGTGGTAATTCTAA-3'),and orf4reverse primer (5'-TGTTCAGTTTTGTTACCTTGATCTTGT-3'); MW1037 forward primer (5'-CAACGTTTGCCGGTGAATC-3'), MW1037 probe (5'-CATGCACAAACTAAGGTTGA-3'), and MW1037 reverse primer (5'-GCGTCCACAACTTTTTTATTTACTTG-3'); sec4 forward primer (5'-ATACATCAAAACATTACGCGAACAC-3'), sec4 probe (5'-CAGAACGTGCACAAGAAGTATTCTCTGAA-3'), and sec4 reverse primer (5'-CTGGGTTCTTGCTGTCTTT-AAGTG-3'); and MW1040 forward primer (5'-CTACAA-TTGCGTCAACAGCAGAT-3'), MW1040 probe (5'-CGA-GCGAAGGATACGGTCCAAGAGAAA-3'), and MW1040 reverse primer (5'-ACCATCATTGTACTCTACGATATT-GTGA-3'). TaqMan real-time PCR analysis was performed for 2 separate experiments, each of which were assayed in triplicate.
RESULTS

Mouse models of sepsis and soft-tissue infection demonstrate that
saeR/S is important during invasive S. aureus disease. MW2 can cause a wide range of infections, from relatively mild skin infections to invasive and rapidly fatal disease [2, 3, 19] . To investigate the role of saeR/S during invasive disease, we used a mouse model of staphylococcal sepsis (figure 3A). All mice infected intravenously with MW2 experienced morbidity and died within 36 h after infection. This result is consistentwiththoseofpreviousstudies [23] .Incontrast,only1mouse
infected with ⌬saeR/S became sick and died (P Ͻ .001). We next compared the ability of wild-type and ⌬saeR/S strains to cause abscesses and dermonecrosis (figure 3B-3D). Abscess volumes in mice infected with wild-type and ⌬saeR/S strains were similar (P Ͼ .05 at all time points except day 5) (figure 3B). In addition, the number of mice with dermonecrosis was comparable between the strains (figure 3C). In a separate experiment, we determined the S. aureus load per abscess. There was no significant difference in the recovered S. aureus load between mice infected with MW2 and mice infected with ⌬saeR/S ( figure 3D ). These results suggest that saeR/S plays a distinct role in pathogenesis and is vital for virulence of MW2 after bloodstream infection.
Absence of saeR/S significantly attenuates survival of MW2 in human blood. To determine whether the observed attenuated virulence of ⌬saeR/S was attributable to reduced survival in blood (i.e., killing by a component of blood), MW2 and ⌬saeR/S were cultured in whole human blood (figure 4). Although there was no statistically significant difference in survival in whole blood between wild-type, complement, and mutant strains after 1 h of incubation, survival and growth of ⌬saeR/S was reduced significantly by 3 h (the mean survival [ϮSD] was ϳ130% Ϯ 118% among the wild-type MW2 strains and ϳ118% Ϯ 157% among the complement ⌬saeR/S strains, compared with Ͻ30% Ϯ 37% among the saeR/S mutant strains; P Ͻ .01 for the comparison of wild-type and saeR/S mutant strains; P Ͻ .05 for the comparison of complemented strains and the saeR/S mutant strains). The attenuated growth or survival of ⌬saeR/S in blood was not the result of increased sus- ceptibility to serum complement (data not shown). Of importance, complementation of the ⌬saeR/S strain with saeR/S restored the wild-type phenotype. The reduced survival of ⌬saeR/S in human blood correlates with the dramatically reduced virulence in the sepsis model ( figure 3A) , and the data indicate that the SaeR/S system is important for invasive S. aureus infection. Because PMNs are the major cellular component of host defense in blood, we hypothesized that the decreased survival of ⌬saeR/S in human blood is the result of increased killing by PMNs.
The saeR/S system is essential for S. aureus survival after PMN phagocytosis. To determine whether decreased survival of the saeR/S mutant strain in blood was attributable to enhanced killing by human PMNs, we evaluated phagocytosis and killing of MW2 and ⌬saeR/S. There was no statistically significant difference in the uptake of MW2 or ⌬saeR/S by human neutrophils (figure 5A). However, survival after uptake was significantly better among MW2 strains at all times that testing was performed (e.g., mean survival [ϮSD] at 1.5 h was 74.6% Ϯ 22% among MW2 strains and 21.6% Ϯ 11.2% among ⌬saeR/S; P Ͻ .001) (figure 5B). Again, complementation of the ⌬saeR/S strain restored the wild-type phenotype (P Ͻ .05 for comparison of MW2 and complement ⌬saeR/S strains with ⌬saeR/S strain) (figure 5C).
SaeR/S promotes lysis of human PMNs by MW2. Pathogenic strains of S. aureus produce numerous toxins, including leukocidins [31] . We have previously shown that MW2 destroys PMNs after phagocytosis [7] . To determine whether saeR/S contributes to the previously observed cytolytic capacity of MW2, we measured lactate dehydrogenase release by human PMNs after phagocytosis of MW2 and ⌬saeR/S (figure 5D). Lysis of human PMNs was significantly reduced during interaction with ⌬saeR/S strains, compared with wild-type strains (mean percentage [ϮSD] of PMNs lysed was 76% Ϯ 5.7% after a 5-h incubation period with MW2, compared with 30% Ϯ 12.5% for PMNs incubated with ⌬saeR/S; P Ͻ .001).
Deletion of saeR/S significantly alters gene expression in MW2. As a first step toward identifying the saeR/S-regulated molecules that contribute to virulence (figure 3), evasion of PMN killing (figure 5B), and PMN lysis ( figure 5D ), we compared the transcriptome of MW2 with ⌬saeR/S during growth in trypticase soy broth (tables 1-4, which do not appear in the print version of the Journal). Deletion of saeR/S significantly altered the MW2 transcriptome and influenced expression of ϳ212 genes (ϳ8% of the MW2 genome with use of a 2.0 fold change in transcript levels as a cutoff value). Transcripts encoded by ϳ3% (80 genes) and ϳ5% (133 genes) of the MW2 genome were up-regulated and down-regulated, respectively, in ⌬saeR/S (tables 1-4, which do not appear in the print version of the Journal). Genes encoding proteins with undefined functions comprised the largest category of genes influenced by saeR/S (ϳ49% of the total genes influenced by saeR/S) (tables 3 and 4, which do not appear in the print version of the Journal). Consistent with observations made by others (15, 17) , deletion of saeR/S is caused by down-regulated expression of genes encoding virulence factors, including hla, hlgA, hlgB, hlgC, and sbi, and adhesins, such as fibrinogen-binding proteins (MW1040 and MW1037). MW1037 (characterized as a hypothetical protein) (table 3, which does not appear in the print version of the Journal) is homologous to SA1000, a fibrinogen-binding protein of S. aureus that has been shown to be important in adherence and internalization of S. aureus by endothelial cells and is regulated by saeR/S in the S. aureus WCUH29 strain [15] . Deletion of saeR/S in the MW2 strain also altered expression of genes encoding staphylococcal exotoxin 26 (set26; down-regulated ϳ16.46-fold in ⌬saeR/S) and staphylococcal enterotoxin C4 (sec4; downregulated 13.31-and 247.3-fold in midexponential and early stationary growth phases, respectively, in ⌬saeR/S). Moreover, several S. aureus virulence factors that were previously shown to be induced during PMN phagocytosis of MW2 [7, 23] were down-regulated in the saeR/S mutant strain (table 5) . Collectively, Ͼ12 genes associated with virulence that were upregulated after PMN phagocytosis of MW2 were downregulated in the saeR/S mutant strain, which suggests that the SaeR/S regulatory system plays an important role in S. aureus survival after PMN phagocytosis.
Transcripts involved in metabolism were also affected by deletion of saeR/S. For example, several transcripts involved in carbohydrate transportation and metabolism (lacA-G were upregulated) and amino acid transportation and metabolism (ureA-G were up-regulated and arcA-D were down-regulated) were differentially regulated in ⌬saeR/S (tables 1 and 2, which do not appear in the print version of the Journal). Several genes involved in nucleotide transportation and metabolism (including purK, purC, purQ, purL, purF, purM, purN, purH, and purD) were down-regulated in ⌬saeR/S (table 1, which does not appear in the print version of the Journal). Thus, our data suggest that the SaeR/S regulatory system of MW2 has pleiotropic regulatory affects and alters expression of genes with diverse functions.
Complementation of ⌬saeR/S with saeR/S restores the wildtype genotype. To confirm that differences in gene expression between ⌬saeR/S and wild-type MW2 strains were the result of an isogenic mutation in saeR/S, we used TaqMan real-time reverse transcription PCR to verify changes of selected transcripts ( figure 1A and 1B) . Using growth conditions identical to those used for the microarray experiments, we measured transcript levels in 7 genes by TaqMan analysis of MW2, ⌬saeR/S, and complement ⌬saeR/S strains. Complementation of the ⌬saeR/S mutant strain restored gene expression of saeR/S to transcript levels comparable to those measured in wild-type MW2 ( figure  1A ). TaqMan analysis also confirmed changes in gene expression that were identified by microarray analysis (figure 1B and tables 1 and 3, which do not appear in the print version of the Journal).
DISCUSSION
In the present study, we created an isogenic saeR/S mutant in strain MW2 and investigated the role of this gene regulatory system in staphylococcal pathogenesis. We found that absence of saeR/S rendered MW2 essentially nonvirulent in a mouse model of staphylococcal sepsis but had virtually no effect on abscess formation ( figure 3) . Moreover, the mutant strain was significantly attenuated in its ability to survive after PMN phagocytosis (figure 5B), and microarray analysis revealed that deletion of saeR/S caused down-regulation of transcripts encoding several virulence factors in MW2 that were differentially expressed after PMN phagocytosis (table 5) [7, 23] .
The observed dichotomous phenotype of ⌬saeR/S during 2 very different types of infection is intriguing and suggests that 2-component gene regulatory systems influence the type of staphylococcal infection on the basis of the initial site of infection. This idea is supported by Wright et al. [32] , who concluded that agr activation and expression is essential for staphylococcal lesion development. The authors hypothesize that rapid agr activity precedes the innate immune response, which allows S. aureus to establish a critical quorum that is capable of producing large amounts of toxins to neutralize the bactericidal activity of the recruited PMNs. In our murine sepsis model, S. aureus strains encountered PMNs immediately; therefore, quorum sensing activation of the staphylococcal virulon was unlikely to occur under these conditions. Instead, we hypothesize that, during bloodstream infection, the staphylococcal virulon is at least in part regulated by the SaeR/S gene regulatory system. Sepsis is the result of a complex cascade of events resulting in multiorgan failure that include abnormal cytokine activation, neutropenia, and coagulation dysfunction [33] . Because cytolytic toxins have been shown to promote release of inflammatory mediators and because SaeR/S regulates release of cytolytic toxins, it is possible that these molecules are responsible at least in part for the observed mortality in the mouse sepsis model ( figure 3) . Alternatively, deletion of saeR/S resulted in the down-regulation of several genes that function or have putative functions that modulate complement, including sbi, MW1040, MW1041, and MW1037. NOTE. Genes listed were decreased 2.0-fold in expression, compared with wild-type genes, at 1 growth phase tested. ES, early stationary phase of growth (optical density at 600 nm, 2.0); ME, midexponential phase of growth (optical density at 600 nm, 0.75).
Staphylococcal immunoglobulin G-binding protein (Sbi) is a secreted protein that can inhibit all 3 complement pathways through consumption of C3 [34] . MW1040 is homologous with extracellular fibrinogen binding protein, and MW1037 is homologous with extracellular complement binding protein [35] . Extracellular fibrinogen binding protein and extracellular complement binding protein are complement evasion proteins that target C3b-containing convertases [35] , and MW1041 is homologous with chain A of the staphylococcal complement inhibitor [36] . These findings are important, because complement promotes PMN recruitment, phagocytosis, and activation. In our abscess model, PMN recruitment did not appear to be affected by saeR/S ( figure 3C and 3D) . However, the influence of saeR/S on PMN recruitment and/or activation after bloodstream infection remains to be determined.
Our microarray data support observations made by other researchers about genes influenced by saeR/S and also identify many additional genes under the influence of saeR/S in MW2 (tables 1-4, which do not appear in the print version of the Journal). Differences in results are likely attributable to the strains studied, growth phases investigated, type of microarray technology used, and genetic constructs used to analyze the influence of saeR/S on S. aureus gene expression. For example, Liang et al. [15] created an saeS mutant in strain WCUH29 and used oligonucleotide microarrays to analyze gene expression during the midexponential (at 3 h) phase of growth. Rogasch et al. [17] used complementary DNA microarrays to analyze gene expression in saeS deletion mutants constructed in S. aureus strains COL and Newman during the late-exponential and stationary phases of growth. In comparison, our study analyzed an saeR/S deletion mutant in MW2 with use of oligonucleotide microarrays designed specifically with the genome of this strain. Moreover, we analyzed gene expression during the midexponential and early stationary phases of growth. These differences likely account for some of the differences observed between the studies. For example, Rogasch et al. [17] reported that an saeS deletion in the COL strain did not up-regulate gene expression. Liang et al. [15] showed that deletion of saeR/S in the WCUH29 strain up-regulated the agr regulatory system. In contrast, we observed ϳ78 genes that were up-regulated in saeR/S (tables 2 and 4, which do not appear in the print version of the Journal), as well as down-regulation of the agr operon in saeR/S (agrA, agrC, agrD, agrB, and hld with decreases of 2.0-fold, 1.8-fold, 2.0-fold, 2.0-fold, and 1.9-fold, respectively). Collectively, microarray data suggest that the influence of saeR/S on transcriptional regulation is dependent on multiple factors, including the strain of S. aureus studied [15, 17] .
The ability to rapidly recognize PMNs and/or PMN components is likely to be a virulence strategy used by pathogenic strains of S. aureus. We infer from our published data and the data presented here that interaction with neutrophils activates saeR/S [7, 37, 38] . Group A Streptococcus uses the Ihk-Irr 2-component system to recognize PMN components, including reactive oxygen species and primary granule proteins [39] . Salmonella enterica serovar Typhimurium uses a similar system to recognize host cationic antimicrobial peptides, including C18G, LL-37, polymyxin B, and protegrin, through the PhoP/PhoQ 2-component system [40, 41] . Li et al. [42] described an antimicrobial peptide sensor and regulator in the gram-positive pathogen Staphylococcus epidermidis that responds very specifically to cationic antimicrobial peptides and uses a mechanism that is distinct from the PhoP/PhoQ system [40 -42] . Thus, it appears that recognizing host factors through sensor and/or regulator systems is a strategy maintained and used by a broad range of bacterial pathogens to detect and respond to innate immunity. Palazzolo-Ballance et al. [37] found that saeR/S was upregulated in response to microbicides of human PMNs, including hypochlorous acid, hydrogen peroxide, and azurophilic granules, and Geiger et al. [38] identified promoter activities of saeS in response to subinhibitory concentrations of ␣-defensins.
Collectively, saeR/S appears to play an essential role during S. aureus evasion of innate immunity. Our study provides a foundation from which to pursue specific molecular mechanisms used by S. aureus at the host-pathogen interface and associates a 2-component system with invasive S. aureus disease. Table 4 . Genes without a defined function that were up-regulated in the saeR/S mutant strain during growth in trypticase soy broth. 
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